NWBO 8-K 2026-10-30

NORTHWEST BIOTHERAPEUTICS INC (NWBO) 8-K dated 2026-10-30 — accession 0001104659-26-120669. This URL is the filing, not the NWBO hub.

NORTHWEST BIOTHERAPEUTICS INC (NWBO) is a biotechnology company listed on OTCQB.

NORTHWEST BIOTHERAPEUTICS INC filed a 8-K on 2026-10-30. Accession 0001104659-26-120669.

Cached items: 1.01, 2.03. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported NWBO revenue for 2025-12-31 was $1.4M. Net income was -$60.2M. Revenue was down 0.3% from 2024-12-31 to 2025-12-31. NWBO currently screens at market cap $312.2M.

Not investment advice. The NWBO SEC hub lists recent forms. The stock page is the research view.